Abstract
Failure to control bleeding remains challenging to define, despite many attempts of the community of experts. Even if it is associated with survival, regulatory agencies do not consider this endpoint as a reliable one for clinical trials. Moreover, identifying patients before early rebleeding or at risk of refractory bleeding is probably the most important issue. Mortality at 6 weeks seems to be a reasonable endpoint for RCTs. Refractory bleeding and its attendant mortality remain a challenging condition. Some therapeutic options, besides salvage TIPS, are currently developed but need to be tested in RCTs. As of today, most prognostic variables and scores lack external validation, and a majority include subjective or time-dependent variables and are, therefore, inconsistently evaluated. Identification of solid and unbiased predicting factors of treatment failure and rebleeding have become an urgent need, especially after the demonstration that placement of a TIPS improves survival in patients with acute variceal bleeding and high risk of failure. Identifying the best prognostic factors defining high risk should be our priority. The greatest improvement in the last years in the management of acute variceal bleeding is early TIPS in selected high-risk patients. Selection of patients needs to be refined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370–2379
Garcia-Pagan JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, Luca A et al (2013) Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 58:45–50
D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231
de Franchis R, Baveno VF (2010) Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 53:762–768
Abraldes JG, Villanueva C, Banares R, Aracil C, Catalina MV, Garci APJC, Bosch J (2008) Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 48:229–236
Augustin S, Muntaner L, Altamirano JT, Gonzalez A, Saperas E, Dot J, Abu-Suboh M et al (2009) Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol 7:1347–1354
Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, Keough A et al (2014) A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 146:412–419.e413
Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, Marrero JM et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40:793–801
Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, D’Amico G et al (2008) Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology 47:1604–1614
Augustin S, Altamirano J, Gonzalez A, Dot J, Abu-Suboh M, Armengol JR, Azpiroz F et al (2011) Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol 106:1787–1795
D’Amico G, De Franchis R (2003) Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38:599–612
Al-Freah MA, Gera A, Martini S, McPhail MJ, Devlin J, Harrison PM, Shawcross D et al (2014) Comparison of scoring systems and outcome of patients admitted to a liver intensive care unit of a tertiary referral centre with severe variceal bleeding. Aliment Pharmacol Ther 39:1286–1300
Amitrano L, Guardascione MA, Manguso F, Bennato R, Bove A, DeNucci C, Lombardi G et al (2012) The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol 107:1872–1878
Chen PH, Chen WC, Hou MC, Liu TT, Chang CJ, Liao WC, Su CW et al (2012) Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol 57:1207–1213
Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS (2008) Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 57:814–820
de Franchis R (2000) Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33:846–852
de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176
Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki JP et al (2001) Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 344:23–28
Burroughs AK (2001) Assessment of value of consensus definitions in acute variceal bleeding. Lancet 357:1147–1148
Cales P, Lacave N, Silvain C, Vinel JP, Besseghir K, Lebrec D (2000) Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding. J Hepatol 33:738–741
Thabut D, D’Amico G, Tan P, De Franchis R, Fabricius S, Lebrec D, Bosch J et al (2010) Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. J Hepatol 53:1029–1034
Ahn SY, Park SY, Tak WY, Lee YR, Kang EJ, Park JG, Lee WK et al (2015) Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension. Hepatology 61:1033–1040
Thabut D, Rudler M, Dib N, Carbonell N, Mathurin P, Saliba F, Mallet A et al (2015) Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. Hepatology 61:1024–1032
U.S. Food and Drug Administration (FDA). FDA gastrointestinal drugs advisory committee, In 19 May 2009
Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R (2004) Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40:652–659
Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK (1998) Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 27:1207–1212
Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL (1995) Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 346:865–868
Schmidt ML, Barritt AS, Orman ES, Hayashi PH (2015) Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology 148:967–977
Avgerinos A, Klonis C, Rekoumis G, Gouma P, Papadimitriou N, Raptis S (1991) A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal hemorrhage. J Hepatol 13:78–83
Chong C-F (2005) Esophageal rupture due to Sengstaken-Blakemore tube misplacement. World J Gastroenterol 11:6563–6565
Panes J, Teres J, Bosch J, Rodes J (1988) Efficacy of baloon tamponade in treatment of bleeding gastric and esophageal varices- results in 151 consecutive episodes. Dig Dis Sci 33:454–459
Azoulay D, Castaing D, Majno P, Saliba F, Ichai P, Smail A, Delvart V et al (2001) Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35:590–597
Roessle M (2013) TIPS: 25 years later. J Hepatol 59:1081–1093
Rudler M, Rousseau G, Thabut D (2013) Salvage transjugular intrahepatic portosystemic shunt followed by early transplantation in patients with Child C14-15 cirrhosis and refractory variceal bleeding: a strategy improving survival. Transpl Int 26:E50–E51
Benko L, Danis J, Hubmann R, Kasza G, Gomori E, Roth E, Lorinczy D (2009) DSC examination of the esophagus after implantation of special stents, designed for the management of acute esophagus variceal bleeding: experimental study. J Therm Anal Calorimetry 95:763–768
Hubmann R, Bodlaj G, Czompo M, Benkoe L, Pichler P, Al-Kathib S, Kiblboeck P et al (2006) The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 38:896–901
Zehetner J, Shamiyeh A, Wayand W, Hubmann R (2008) Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc Other Interv Techn 22:2149–2152
Wright G, Lewis H, Hogan B, Burroughs A, Patch D, O’Beirne J (2010) A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc 71:71–78
Dechene A, El Fouly AH, Bechmann LP, Jochum C, Saner FH, Gerken G, Canbay A (2012) Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion 85:185–191
Escorsell A, Cardenas A, Pavel O, Maria Morillas R, Albillos A, Llop E, de la Pena J et al (2013) Self-expandable esophageal metal stent vs balloon tamponade in esophageal variceal bleeding refractory to medical and endoscopic treatment: a multicenter randomized controlled trial. Hepatology 58:1386A–1387A
Fierz FC, Kistler W, Stenz V, Gubler C (2013) Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a swiss multicentric cohort. Case Rep Gastroenterol 7:97–105
Zakaria MS, Hamza IM, Mohey MA, Hubamnn RG (2013) The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: Pilot study. Saudi J Gastroenterol 19:177–181
Vangeli M, Patch D, Burroughs AK (2002) Salvage tips for uncontrolled variceal bleeding. J Hepatol 37:703–704
Vinel JP, Cassigneul J, Louis A, Levade M, Pascal JP (1982) Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis. Surg Gynecol Obstet 155:347–352
Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, Perreault P et al (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126:469–475
Thabut D, Remy A, Carbonell N, Causse X, Coelho J, Cadranel JF, Cervoni JP, Bramli S, Archambeaud I, Ahsoune P, Ehrhard F, Pariente A, Bureau C, Dupuychaffray J, Rostain F, Skinazi F, Vergniol J, Vitte RI, Pelletier AL, Henrion J, Guillygomarc’h A, Combet S, Pauwels A, Club Francophone pour l’Etude de l’Hypertension Portale, Association Nationale desHepato-Gastroentérologues des Hôpitaux Généraux. Prospective observational study of portal-hypertensive bleeding in 914 cirrhotic patients in France (CHOC study) : high proportion of high-risk patients but limited access to TIPS. AASLD 2014.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this paper
Cite this paper
Villanueva, C., O’Beirne, J., Bureau, C., Thabut, D. (2016). A la Carte Treatment of Acute Variceal Bleeding. In: de Franchis, R. (eds) Portal Hypertension VI. Springer, Cham. https://doi.org/10.1007/978-3-319-23018-4_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-23018-4_27
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23017-7
Online ISBN: 978-3-319-23018-4
eBook Packages: MedicineMedicine (R0)